MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijbiomac.2026.151856

Медицинская библиотека · International journal of biological macromolecules · 2026

Anticancer therapeutic efficacy of PEGylated β-galactosidase from Aspergillus terreus in DMBA-induced breast cancer: Toxicological, molecular and histopathological evaluation in Wistar rats.

Balasubramanian Vidya, Loganathan Lavanya, Muthuswamy Karthi, Thimma Mohan Viswanathan, Vani Raju Manikandan, Kaniyur Chandrasekaran Meenakshi, Muthaiyan Ahalliya Rathi, Poorasamy Jeevitha, Palanisamy Chella Perumal, Dominic Sophia, Velliyur Kanniappan Gopalakrishnan

СтатьяПеревод в очереди

Аннотация

Breast cancer remains a leading cause of cancer-related morbidity and mortality among women worldwide, underscoring the need for safer and more effective therapeutic strategies. Polyethylene glycol (PEG) conjugation is a well-established approach to enhance the stability, bioavailability, and in vivo performance of protein/enzymatic therapeutics. To our knowledge, this is the first study to demonstrate PEG conjugation of β-galactosidase and to provide in vivo evidence of its antitumor efficacy. Here, β-galactosidase from Aspergillus terreus was PEGylated using mPEG-NHS (5 kDa) and conjugation was validated by HPLC (retention time shift) and FTIR spectroscopy (PEG-associated ether bands with preserved protein amide signatures). Safety was evaluated following ARRIVE and OECD acute oral toxicity (TG 423) and 28-day repeated-dose oral toxicity (TG 407) protocols, showing no mortality, overt clinical toxicity, or treatment-related changes in hepatic or renal biochemical indices across the tested doses. Antitumor efficacy was assessed in a 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinoma model in female Wistar rats. Oral administration of PEGylated β-galactosidase (50 mg/kg for 30 days) attenuated DMBA-associated metabolic and oxidative disturbances, reflected by reduced lipid peroxidation (malondialdehyde) and restoration of enzymatic (SOD, CAT, GPx, GR, GST) and non-enzymatic (GSH, vitamins C and E) antioxidant defenses. Treatment further normalized membrane-bound ATPase activities, reduced tumor-associated enzyme markers (5'-nucleotidase, γ-glutamyltransferase, cathepsin D), regulated apoptosis-related endpoints (BAX, BCL-XL, P53; caspase-3) and improved mammary tissue histoarchitecture. Collectively, these findings support PEGylated β-galactosidase as a well-tolerated macromolecular candidate with in vivo antitumor potential mediated primarily through redox restoration and apoptosis regulation.

Для цитирования: Balasubramanian Vidya, Loganathan Lavanya, Muthuswamy Karthi, Thimma Mohan Viswanathan, Vani Raju Manikandan, Kaniyur Chandrasekaran Meenakshi, Muthaiyan Ahalliya Rathi, Poorasamy Jeevitha, Palanisamy Chella Perumal, Dominic Sophia, Velliyur Kanniappan Gopalakrishnan. Anticancer therapeutic efficacy of PEGylated β-galactosidase from Aspergillus terreus in DMBA-induced breast cancer: Toxicological, molecular and histopathological evaluation in Wistar rats.. International journal of biological macromolecules. 2026. DOI: 10.1016/j.ijbiomac.2026.151856.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.